Department of Pharmacology and Environmental Toxicology, Dr. A.L.M.P.G. Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, India.
Pharm Biol. 2010 Aug;48(8):869-77. doi: 10.3109/13880200903302838.
The ethanol leaf extract (ELE) of Cassia fistula Linn. (Caesalpinaceae) was evaluated for antiulcer activity against pylorus ligation-induced gastric ulcer. Ranitidine (30 mg/kg b.w.) and ELE at doses of 250, 500, and 750 mg/kg b.w. were administered orally in different groups of rats (n = 6), 1 h prior to pyloric ligation. Four hours after pyloric ligation, the gastric juice was collected for evaluation of various parameters. The antiulcer activity of ELE was evidenced by the significant attenuation of gastric volume, pH, free acidity, and total acidity in the gastric juice of pyloric-ligated rats in a dose-dependent manner, and this protective effect could be due to strengthening of the mucosal defense mechanism. ELE pre-treatment significantly attenuated the fall in status of sialic acid and fucose accompanied by an increase in hexose, hexosamine, total non-amino polysaccharide, total carbohydrate, and C:P ratio in the gastric juice of pylorus-ligated rats, and this effect could be due to protection of the mucosal barrier system. ELE pre-treatment significantly prevented the increase in LPO and SOD accompanied by a fall in CAT, in the gastric juice of pyloric-ligated rats. This protective ability of ELE against pylorus ligation-induced gastric ulcer could be attributed to its free radical scavenging and antioxidant properties. Higher doses of ELE (750 mg/kg b.w.) produced maximum antiulcer activity comparable to ranitidine treatment. In essence, the antiulcer activity of ELE could be attributed to (i) a decrease in gastric acid secretion, (ii) protection of the mucosal barrier and restoration of mucosal secretions, (iii) inhibition of free radical generation or prevention of lipid peroxidation, and (iv) free radical scavenging or antioxidant properties.
罗望子叶乙醇提取物(ELE)对结扎幽门引起的胃溃疡的抗溃疡活性进行了评价。雷尼替丁(30mg/kg b.w.)和 ELE 以 250、500 和 750mg/kg b.w.的剂量分别在不同剂量的大鼠(n=6)中口服给药,在幽门结扎前 1 小时。幽门结扎后 4 小时,收集胃液评估各种参数。ELE 的抗溃疡活性表现为胃容积、胃液 pH 值、游离酸度和总酸度呈剂量依赖性显著降低,这种保护作用可能是由于增强了黏膜防御机制。ELE 预处理可显著减轻唾液酸和岩藻糖水平下降,并伴有六糖、己糖胺、总非氨基多糖、总碳水化合物和 C:P 比值增加,这可能是由于保护了黏膜屏障系统。ELE 预处理可显著防止 LPO 和 SOD 增加,同时伴有 CAT 下降,在结扎幽门的大鼠胃液中。ELE 对结扎幽门引起的胃溃疡的这种保护作用可能归因于其清除自由基和抗氧化特性。ELE 的高剂量(750mg/kg b.w.)产生的最大抗溃疡活性可与雷尼替丁治疗相媲美。从本质上讲,ELE 的抗溃疡活性可能归因于(i)胃酸分泌减少,(ii)保护黏膜屏障和恢复黏膜分泌物,(iii)抑制自由基生成或防止脂质过氧化,以及(iv)清除自由基或抗氧化特性。